Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3924635 A
Publication typeGrant
Publication dateDec 9, 1975
Filing dateJun 12, 1974
Priority dateAug 14, 1972
Publication numberUS 3924635 A, US 3924635A, US-A-3924635, US3924635 A, US3924635A
InventorsHakim Salomon
Original AssigneeHakim Salomon
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Ventricular shunt having a variable pressure valve
US 3924635 A
Abstract  available in
Images(2)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

Unite States Patent 1191 [111 3,

Hakim Dec. 9, 1975 [54] VE T I SHUNT HAVING A 2,969,066 1/1961 Holter et al 12s/350 v VARIABLE PRESSURE VALVE 3,109,429 11/1963 Schwartz 128/350 V 3,477,438 11/1969 Allen et al 128/349 BV Inventor: Salomon Hakim, Carrera 13, 6, 3,654,932 4/1972 Newkirk 128/350 v Bogota, Colombia [22 Filed; June 12, 1974 Primary ExaminerRichard A. Gaudet Assistant Examiner-Henry J. Recla PP 9434 Attorney, Agent, or FirmKenway & .lenney Related US. Application Data [62] Division of Ser. No. 280,451, Aug. 14, 1972, [57] ABSTRACT Proper cerebral hydraulic conditions may be mainabandoned.

tained in the treatment of hydrocephalus by means of [52] US. Cl. 128/350 V; 128/274 a entricular Shunt having a variable operating pres- [51] Int. Cl. A61M 27/00 Sure al e, Such that the CSF pressure may be con- [58] Field of Search 128/350 V, 350 R, 349 BV, trolled according to the size of the ventricle to correct 128/274; 251/342 the imbalance of forces developed by the CSF pressure against the ventricular area. These forces can be [56] Reference Cited sensed in the dural region and utilized to control the UNITED STATES PATENTS operating pressure setting of the valve.

1 Claim, 8 Drawing Figures U.S. Patent Dec.9,1975 Sheet10f2 3,924,635

FIG.

US. Patent Dec. 9, 1975 Sheet 2 of2 3,924,635

FIG. 4

FIG. 5

I'll ,4154% VENTRICULAR SIIUNT HAVING A VARIABLE PRESSURE VALVE This is a division, of application Ser. No. 280,451 filed Aug. 14, 1972 and now abandoned.

BACKGROUND OF THE INVENTION The treatment of hydrocephalus frequently involves the provision of a ventricular shunt for draining excess cerebral spinal fluid (CSF) from the ventricle in the brain. The shunt generally consists of a cerebral catheter inserted through the brain tissue into the ventricle and connected through a one-way valve system to drain into the jugular vein or another resevoir in the body. The shunt provides for removal of excess CSF from the ventricle and consequent reduction in its size. Control over the drainage is provided by the one-way valve, which normally operates at a fixed closing pressure.

Although hydrocephalus is frequently associated with an abnormally high CSF pressure, there are numerous cases where hydrocephalus is associated with the CSF at normal pressure, see Ojemann, Robert 6., Normal Pressure Hydrocephalus, Clinical Neurosurgery, Vol. 18 pp. 337-370, 1971.

An analysis of the hydromechanics involved in normal pressure hydrocephalus syndrome leads to the conclusion that the effective force expansion from the ventricles is not dependant on the CSF pressure alone, but is the product of the CSF pressure and ventricular area. In other words, in the presence of ventricular enlargement a normal pressure is acting. Thus, in normal pressure hydrocephalus the ventricle remains enlarged, because the area subjected to the pressure of the CSF is larger than normal and hence the total force on the brain tissue, the product of the pressure times the area, is excessive. (See S. Hakim and R. D. Adams, The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure: Observations on cerebrospinal fluid hydrodynamics. J. Neural. Sci., Vol. 2 pp. 307327. 1965).

In addition to the forces developed by the CSF pressure, the brain tissue is subjected to a counterforce developed by the venous pressure within the intraparenchymatous system, within the brain tissue itself. Wheras CSF pressure tends to enlarge the ventricles, the venous pressure tends to reduce their size. These two forces are normally in balance so that the ventricular size does not increase nor decrease, but remains constant through life.

Accordingly, the aim in treating hydrocephalus by shunting procedures is not merely to arrest the condition, but to restore, as much as possible, normal ventricular size. Once hydrocephalus has developed, this restoration is accomplished by reversing the imbalance of the two forces acting on the brain parenchyma. The CSF pressure must be reduced by an amount proportional to the size of the ventricles to offset the increase force developed by virtue of their enlarged area. Then the forces developed within the venous system can cause the compressed brain tissue to spring back against the lower CSF force, and the venous bed will regain its lost volume and free flow. This way brain metabolism becomes normal and the tissue recuperates.

In treating hydrocephalus, a reduced CSF pressure is established by a shunt which includes a on'eway valve having an operating pressure equal to the desired CSF pressure. With the shunt in place the CSF pressure remains at a maximum level determined by the implanted valve and drainage of CSF fluid from the ventricles continues as long as CSF pressure is not less than the operating pressure of the valve. Since the correction of normal pressure hydrocephalus requires the implantation of a valve having a lower than normal operating pressure, e.g. 3040 mm. H O, the CSF pressure remains lower than normal as the ventricle decreases in size. On the other hand the venous pressure remains normal; as a consequence the force imbalance is reversed. The venous system force becomes greater than the CSF system force because of the progressively smaller ventricular area and lowered CSF pressure. Accordingly, once the ventricle is again normal size the intraventricular CSF pressure must be brought back to normal levels. Otherwise there is not enough force within the ventricle to keep the brain normally expanded.

If on the other hand lower than normal CSF. pressure is maintained, overcorrection of hydrocephalus may cause undesirable pathological consequences, such as swelling or engorgement of the veins, cerebral edema, slit ventricles" and microcephaly. In other cases complications such as subdural hygromas, hematomas and overlapping of the skull bones are known to occur.

The ability to control the CSF pressure with respect to the ventricular area is important to the proper treatment of hydrocephalus, because proper balance within the brain, must eventually be established.

In brief the problem in correcting and maintaining correct normal hydrodynamic balance in the cranial cavity is to maintain the interventricular CSF at a pressure corresponding to the ventricular area. When the ventricle attains normal size, the valve provided for the initial drainage should be replaced with one having a closing pressure equivalent to a normal CSF pressure (125-150) mm. H O.

To date there has been little recognition of the problem of maintaining the correct balance of CSF pressure, ventricular area and venous pressure within the brain. 7 In an ideal shunt system the valve should provide for initial drainage at a lower than normal pressure and thereafter operate at an operating pressure that maintains the correct intercranial balance.

Accordingly, in one aspect this invention provides a ventricular shunt valve having means to adjust and vary the valve operating pressure with respect to ventricular area such that the proper balance of forces within the cranium may be maintained.

In another aspect the invention makes use of the fact that the brain tissue is itself a viscoelastic solid which transmits the force developed at the ventricles outwardly to the dura region. This force may be sensed and utilized to control the operating pressure of the ventriculoatrial shunt valve appropriately to maintain proper drainage condition and balance of forces.

BRIEF DESCRIPTION OF THE INVENTION drainage of CSF from the ventricle at a properly low valve operating pressure (e.g. 45 mm. H O) when the 3 force of the CSF is excessive, and to provide for an elevated operating pressure as the brain tissue relaxes and the ventricular area decreases.

Applicant has discovered that the force on the brain resulting from the CSF pressure exerted over the area of the ventricle is transmitted through the brain tissue as a viscoelastic solid and may be sensed in the subdural space where the brain lies adjacent to the skull. This invention features a sensor adapted to be inserted into the dural region between the brain and the skull, in as sociation with a ventricular valve having a working pressure that varies inversely with the force applied to the sensor.

In the preferred embodiments of the invention, inverse variation of the operating pressure of the valve is provided by a feedback arrangement, preferable hydraulic, wherein the force applied to the sensor is transmitted to counteract the spring bias which controls the operating pressure, thus to lower the operating pressure as the force increases. The spring which is biased to hold the valve closed, is unloaded in response to the force applied by the brain to the sensor.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT The preferred embodiment of this invention is described below with reference to the accompanying drawings in which:

FIG. 1 is a schematic illustration showing the valve system in its physiological enviomment;

FIG. 2 is a longitudinal cross-sectional view of the preferred valve mechanism and sensor of this invention;

FIG. 3 is a longitudinal cross-sectional view illustrating an embodiment featuring a resilient slotted tube valve mechanism;

FIG. 4 is a longitudinal cross-sectional view illustrating a valve mechanism featuring a mechanical brain force sensing control element;

FIG. 5 is a plan view showing the implantation of the valve mechanism illustrated in FIG. 4;

FIG. 6 is a longitudinal cross-sectional view, including a partial sagital section, illustrating a resilient slotted tube valve mechanism directly operable by brain forces;

FIG. 7 is a top plan view of the embodiment shown in FIG. 6; and

FIG. 8 is a transverse cross-section taken in 88 in FIG. 7.

The implantation of the ventricular shunt in illustrated in FIG. 1. A ventricular catheter 50 inserted through a burr holw 52 in the skull 54 and through the brain tissue 58 into the ventricle 56 connects through a one-way drainage valve 60 to a drainage catheter 62 which will normally lead to the right artium, the peritoneal cavity or some other suitable reservoir. The improved shunt valve of this invention is contained in the valve 60. The force exerted on the brain is sensed by a fluid filled bladder 24 which hydraulically connects by tube 25 to the valve 60 mechanism described below. The sensing bladder is inserted also through the burr hole, and preferably through the dura] membrain 64 to lie against the arachnoidal membrain 66 over one or more convolutions e.g. 68. Best response to the forces in the brain require close association of the sensing bladder with the brain tissue (cortex). The subarachnoid space surrounding the convolutions is itself subject to CSF pressure, and would tend to give a pressure,

4 rather than a force, response to a sensor output. The object, it will be noted, is to sense the force exerted by the brain tissue as distinguished from the pressure of the CSF.

As in general with ventricular shunts the entire drainage assembly is ultimately covered and held in place by the scalp (not shown).

The hydraulic servo shunt valve of this invention as embodied in FIG. 2 constructed generally as described in applicants US. Pat. No. 3,288,142, and features a housing 10, a valve body 12 formed with a conical valve seat 15 which forms the outlet from an inlet channel 14. A spherical valve member 16, held down by a spring 18, rests within the conical seat and maintains the valve closed until the fluid pressure at this inlet is sufficient to overcome the bias force of the spring.

The spring 18, is mounted on a base plate 20 which is pivoted to the body 12 at the end of the-spring away from the valve sphere. A preloading spring 21 extends from a forward shoulder 19 of the body and positions the base plate 20 for normal or maximum valve spring bias. The base plate 20 lies in spaced relation to a re- -cess portion of the valve body on which is mounted a valve bladder 22 which is hydraulically connected by tube 25 to the sensing bladder 24. The valve bladder 22 is constructed to expand when hydraulically loaded to push the base plate 20 against the force of the preloading spring 21 and thereby unload the valve spring by moving it in the direction away from the valve sphere 16. The valve spring 18 is thus unstrained such that the force applied to the sphere is reduced, correspondingly reducing the working pressure of the valve; which is the fluid pressure at the inlet required to open the valve. When implanted the outward force exerted by the brain is applied to the sensing bladder 24 situated in the subdural region between the brain and the skull, and is transmitted hydraulically to the valve bladder 22. Thus when the force exerted by the CSF pressure applied over the ventricular area is increased, the operating pressure of the valve is reduced, and vice versa. Accordingly as the hydraulic brain contracts from CSF drainage, the resultant reduction in the brain force brings about an increased operative pressure effective to maintain proper drainage and a balance of forces.

Both the sensing bladder 24 and the valve bladder 22 are conveniently constructed of silicone rubber discs cemented together at their edges by means of silicone cement which may be of the RTV type or polymerizable by ionizing radiation. Silicone tubing 25 attached to the discs provides for hydraulic connection between the bladders. The bladders and tubing are conveniently filled with a radiopaque oil such as ethyl iodophenyl undecylate which provides appropriate viscous dampening of the valve mechanism, permits the hydraulic servo connection to be radiologically viewed, and is a safe material frequently used in myelography.

It will be understood that the valve mechanism described in FIG. 2 is the downstream end of the check valve pair described in US. Pat. No. 3,288,142, and is mounted in a flexible length of hollowing tubing 11 which surrounds the housing 10.

The actual construction is more or less conventional,

with stainless steel being preferred for the housing 10, valve body 12, spring 18, base plate 20 and preloading spring 21. The spherical valve member 16 is preferably synthetic sapphire. The biasing spring 18 is spot-welded to the base plate 20 and the preloading spring 21 is spot-welded to the transverse shoulder 19. The pivotal mounting of the base plate to the downstream end of the valve body consists of a pin member 23 spot-welded to the lower side of the base plate 20, received at its ends within sleeves 26, conveniently formed of pieces of hypodermic needle tubing, spot-welded to the top side of the downstream end of the valve body 12. The tube passes through an opening 27 in the valve body 12 and also through the tubing 11 to which it may be sealed by silicone cement.

Implantation of the valve of this invention in a ventriculoatrial shunt system follows standard surgical procedures, with the additional procedure of inserting the sensing bladder 24 into the subdural region. Most conveniently this is introduced through the burr hole and then laterally a short distance away to lie between the brain and the skull.

After the system has been implanted, it may be desirable to make hydraulic adjustments to the servo connection to insure that the valve will open and close properly in response to variations in the force at the sensor. This may be accomplished by shimming the sensor with thin pieces of silicone, or by injecting or removing fluid with a hypodermic needle, preferably through a side branch tube (not shown) which may subsequently be sealed.

In the emb diment illustrated in FIG. 3 the valve consists in a resilient hollow closed tube 70 formed with a longitudinal slit 72. The CSF fluid enters the valve tube 70, and under sufficient pressure causes the slit 72 to open for drainage. The slit is also under the control of an internal spherical bladder 22a, hydraulically connected to the sensing bladder 24 and expansible under hydraulic pressure to urge the slit to open.

In the embodiment illustrated in FIGS. 4 and 5, the construction is generally as described with reference to FIG. 2 with the exception that the control mechanism consists of a pin 76 mounted to the underside of the base plate 20, passing through a silicone rubber seal 78. The pin 76 is adjustably connected, e.g. threaded, to a sensing button 80, adapted to be placed in contact with the exterior of the brain in the dural region. The threaded engagement between the pin 76 and the sensing button 80 provides for adjustment to the individual patient.

The mounting of this embodiment is illustrated in FIG. 5 and features two burr holes 85 and 86, the former accommodating the catheter 50 and the latter accommodating the sensing mechanism. The valve mechanism is conveniently attached to the skull by a mounting pin 90 which passes through the valve body 12 and terminates in eyes by which the valve can be fastened to the skull, e.g. by screws 92.

In the embodiment illustrated in FIGS. 6, 7, and 8, the valve mechanism is contained within a resilient chamber 102, e.g. silicone rubber, formed for direct placement in the dural region in contact with the brain. The catheter 50 leads into the chamber 102 and terminates in a resilient closed tube having a transverse slit 108 on a side wall protion. The top and bottom of the tube 100 contact opposite top and bottom walls of the chamber 102 and may incorporate small metal discs 106. A drainage catheter 104 leads from the chamber 102.

In operation, sufficient CSF pressure will cause the slit 108 to open and provide drainage from the catheter 50 into the chamber 102. Should excessive forces develop, the chamber 102 becomes squeezed and the discs 106 compress the tube 100 causing the slit 108 to tend to open. Drainage at a lower CSF pressure is thus provided. As the brain contracts the force applied by the discs 106 is lessened and an increased CSF pressure becomes necessary for drainage. Thus proper drainage conditions and balance of forces may be maintained.

From the foregoing it will be noted that this invention has been described with specific reference to its prefe'rred embodiment, it is contemplated that numerous modifications and alternatives will readily occur to those skilled in the art and familiar with the principles herein disclosed and that such may principles herein disclosed and that such may be adapted or utilized without departing from the scope of this invention.

Having thus disclosed my invention, I claim and desire to secure by Letters Patent:

1. A cerebrovascular shunt valve comprising a resilient valve body adapted to be inserted into the dural region, said valve body having opposed wall portions adapted to bear against the skull and the brain respectively;

a resilient tube which extends into said valve body between said wall portions and is adapted for connection to a ventricular catheter, the end of the tube being closed within the valve body, there being a slit in the side wall of the tube within said valve body for communicating CSF from said catheter into said valve body, said slit extending in a direction normal to the direction of the longitudinal axis of the tube and positioned between said opposed wall portions thereby being oriented with respect to the wall portions of said valve body to produce opening of said slit when said wall portions are driven against said tube by pressure of the brain against the skull; and

outlet means for venting CSF from said valve body to a location outside of the skull.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2755060 *Dec 3, 1951Jul 17, 1956Raymond Twyman LReinforced flexible wall valve structure
US2969066 *Oct 2, 1956Jan 24, 1961Holter CompanyDevice for draining ventricular fluid in cases of hydrocephalus
US3109429 *Jan 30, 1962Nov 5, 1963Samuel SchwartzVentriculo-venous shunt device for treatment of hydrocephalus
US3477438 *Apr 17, 1967Nov 11, 1969Dwight L AllenCatheter having one-way inflations valve
US3654932 *Nov 26, 1969Apr 11, 1972Newkirk John BSurgical drain for shunting fluid
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US4156422 *Jun 2, 1977May 29, 1979Messerschmitt-Bolkow-Blohm GmbhApparatus for treating hydrocephaly
US4675003 *Dec 23, 1985Jun 23, 1987Cordis CorporationThree stage pressure regulator valve
US4676772 *Dec 23, 1985Jun 30, 1987Cordis CorporationAdjustable implantable valve having non-invasive position indicator
US4681559 *Dec 23, 1985Jul 21, 1987Cordis CorporationFor controlling the passage of body fluids from location to location
US4714458 *Dec 23, 1985Dec 22, 1987Cordis CorporationFor regulating the flow of fluid from one location to another
US4714459 *Dec 23, 1985Dec 22, 1987Cordis CorporationThree stage intracranial pressure control valve
US4729762 *Dec 23, 1985Mar 8, 1988Cordis CorporationThree stage implantable pressure relief valve with adjustable valve stem members
US4776838 *Jul 10, 1987Oct 11, 1988Cordis CorporationSurgically implantable valve for controlling cerebrospinal fluid
US4776839 *Oct 21, 1986Oct 11, 1988Cordis CorporationThree stage implantable pressure relief valve with improved valve stem member
US4781672 *Oct 21, 1986Nov 1, 1988Cordis CorporationThree stage implantable flow control valve with improved valve closure member
US4840617 *Aug 24, 1988Jun 20, 1989Thomas Jefferson UniversityCerebral and lumbar perfusion catheterization apparatus for use in treating hypoxic/ischemic neurologic tissue
US4861331 *Apr 22, 1988Aug 29, 1989Pudenz-Schulte Medical Research Corp.Implantable shunt system and method of assembly
US4867740 *Mar 24, 1988Sep 19, 1989Pudenz-Schulte Medical Research Corp.Multiple-membrane flow control valve and implantable shunt system
US4946448 *Oct 23, 1989Aug 7, 1990Kendall Mcgaw Laboratories, Inc.Check valve for use with intravenous pump
US5336166 *Dec 17, 1992Aug 9, 1994Cordis CorporationThree stage implantable valve
US5368556 *Mar 7, 1994Nov 29, 1994Cordis CorporationImplantable drainage valve for the treatment of hydrocephalus
US5437627 *Sep 14, 1993Aug 1, 1995Cordis CorporationImplantable valve for the treatment of hydrocephaly
US5913852 *Oct 28, 1997Jun 22, 1999Nemours FoundationTo drain cerebrospinal fluid from a ventricle of a brain
US6113553 *Aug 18, 1998Sep 5, 2000Lifesensors, Inc.Telemetric intracranial pressure monitoring system
US6544208Dec 29, 2000Apr 8, 2003C. Ross EthierImplantable shunt device
US7513883 *Mar 22, 2006Apr 7, 2009Glenn Bradley JSubarachnoid epidural shunt
US7559912Sep 30, 2004Jul 14, 2009Codman & Shurtleff, Inc.High pressure range hydrocephalus valve system
US8043247Apr 6, 2009Oct 25, 2011Glenn Bradley JSubarachnoid epidural shunt
US8088092Jul 9, 2009Jan 3, 2012Codman & Shurtleff, Inc.High pressure range hydrocephalus valve system
Classifications
U.S. Classification604/9, 604/118, 604/247
International ClassificationA61M27/00
Cooperative ClassificationA61M27/006, A61M2027/004
European ClassificationA61M27/00C2